why choose us

First received: March 24, 2023

Clinical Trial: OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Dry Eye Syndromes

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-masked, Study to Evaluate the Efficacy and Safety of OTX-DED (Dexamethasone Intracanalicular Ophthalmic Insert) for the Short-term Treatment of the Symptoms of Dry Eye Disease (DE

Brief Summary: To assess the efficacy and safety of OTX-DED for the short-term treatment of the symptoms of DED

Read more